Gain Therapeutics (GANX) Receivables (2020 - 2026)
Gain Therapeutics (GANX) posted quarterly Receivables of $763606.0 for Q1 2026, up 19.51% year-over-year from $638961.0 in Q1 2025, and up 47.67% quarter-over-quarter from $517094.0 in Q3 2025.
Gain Therapeutics (GANX) Receivables (2020 - 2026) Analysis & Trends
Gain Therapeutics' Receivables history runs 6 years deep, the most recent figure standing at $763606.0 for Q1 2026.
- In Q1 2026, Receivables rose 19.51% year-over-year to $763606.0; the TTM figure through Mar 2026 stood at $763606.0 (up 19.51% YoY), while the FY2025 annual figure was $622992.0, up 25.94% from the prior year.
- Receivables for Q1 2026 stood at $763606.0, up from $517094.0 in the prior quarter.
- The five-year high for Receivables was $1.1 million in Q2 2025, with the low at $87430.0 in Q4 2022.
- The 4-year median for Receivables is $578027.5 (2025), against an average of $599693.0.
- Peak annual rise in Receivables reached 19.51% in 2026, while the deepest fall reached 19.51% in 2026.
- Gain Therapeutics' Receivables stood at $87430.0 in 2022, then jumped by 465.81% to $494684.0 in 2024, then climbed by 4.53% to $517094.0 in 2025, then soared by 47.67% to $763606.0 in 2026.
- Business Quant data shows GANX's Receivables at $763606.0 in Q1 2026, $517094.0 in Q3 2025, and $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.76 Bn | 130.91 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.15 Bn | 78.15 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.45 Bn | 59.27 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 57.08 Bn | 51.94 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.90 Bn | 27.59 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 27.76 Bn | 9.37 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | - |
| 10 | Gain Therapeutics | 86.62 Mn | 86.62 Mn | - | 821,212.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 821,212.00 |
| Mar 31, 2026 | 763,606.00 |
| Sep 30, 2025 | 517,094.00 |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 638,961.00 |
| Dec 31, 2024 | 494,684.00 |
| Dec 31, 2022 | 87,430.00 |
| Sep 30, 2021 | 24,713.00 |
| Jun 30, 2021 | 353,166.00 |
| Mar 31, 2021 | 4,486.00 |
| Dec 31, 2020 | 8,548.00 |